A critical review of the SAFE strategy for the prevention of blinding trachoma

Lancet Infect Dis. 2003 Jun;3(6):372-81. doi: 10.1016/s1473-3099(03)00659-5.

Abstract

Trachoma is an ocular disease caused by repeated infection with Chlamydia trachomatis. It is the leading cause of infectious blindness globally, responsible for 5.9 million cases of blindness. Although trachomatous blindness is untreatable, it is eminently possible to prevent and the World Health Organization promotes the use of the SAFE strategy (surgery to treat end-stage disease, antibiotics to reduce the reservoir of infection, facial cleanliness, and environmental improvement to reduce transmission of C trachomatis) for this purpose. In this review we have assessed the evidence base supporting the elements of the SAFE strategy. We find strong support for the efficacy of the surgery and antibiotics components, although the optimal antibiotic regimens have not yet been established. The evidence for an effect of health education and environmental improvement is weaker, and depends mostly on cross-sectional observational studies.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents
  • Blindness / prevention & control
  • Chlamydia trachomatis
  • Communicable Disease Control / organization & administration*
  • Cross-Sectional Studies
  • Developing Countries
  • Environmental Exposure / prevention & control*
  • Evidence-Based Medicine
  • Humans
  • Hygiene
  • Trachoma / prevention & control*
  • Water Purification
  • World Health Organization

Substances

  • Anti-Bacterial Agents